CMPS
COMPASS Pathways plc · Healthcare · Biotechnology
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 60 | +9 | 28.76M | $406.90M | +13 | −4 |
| Q1 2026 | 52 | +2 | 25.39M | $140.32M | +6 | −4 |
| Q4 2025 | 49 | +2 | 17.79M | $122.72M | +2 | — |
| Q3 2025 | 11 | 0 | 9.36M | $53.63M | +1 | −1 |
| Q2 2025 | 8 | -1 | 4.28M | $11.98M | — | −1 |
| Q1 2025 | 8 | -1 | 5.73M | $16.40M | — | −1 |
| Q4 2024 | 9 | +1 | 7.15M | $27.03M | +1 | — |
| Q3 2024 | 7 | +1 | 11.59M | $73.00M | +1 | — |
| Q2 2024 | 6 | — | 9.78M | $59.07M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 3.67M | — | $22.16M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 3.67M | — | $22.16M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Millennium Management ✦ | 3.38M | — | $20.43M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | ARK Investment Management ✦ | 2.10M | — | $12.69M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 348.54K | — | $2.11M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 263.80K | — | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 16.20K | — | $97,841 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 190 holders, 92.50M shares, $510.22M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.